Literature DB >> 19438396

Efavirenz and nevirapine interactions with rifampicin: resolving the dilemmas?

Umesh G Lalloo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19438396     DOI： 10.1086/599115

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  4 in total

1.  Integration of antiretroviral therapy with tuberculosis treatment.

Authors:  Salim S Abdool Karim; Kogieleum Naidoo; Anneke Grobler; Nesri Padayatchi; Cheryl Baxter; Andrew L Gray; Tanuja Gengiah; Santhanalakshmi Gengiah; Anushka Naidoo; Niraksha Jithoo; Gonasagrie Nair; Wafaa M El-Sadr; Gerald Friedland; Quarraisha Abdool Karim
Journal:  N Engl J Med       Date:  2011-10-20       Impact factor: 91.245

2.  Changes to antiretroviral drug regimens during integrated TB-HIV treatment: results of the SAPiT trial.

Authors:  Anushka Naidoo; Kogieleum Naidoo; Nonhlanhla Yende-Zuma; Tanuja N Gengiah; Nesri Padayatchi; Andrew L Gray; Sheila Bamber; Gonasagrie Nair; Salim S Abdool Karim
Journal:  Antivir Ther       Date:  2013-10-31

Review 3.  Prevalence of drug interactions in hospital healthcare.

Authors:  María Espinosa-Bosch; Bernardo Santos-Ramos; María Victoria Gil-Navarro; María Dolores Santos-Rubio; Roberto Marín-Gil; Paloma Villacorta-Linaza
Journal:  Int J Clin Pharm       Date:  2012-09-11

4.  Plasma concentrations, efficacy and safety of efavirenz in HIV-infected adults treated for tuberculosis in Cambodia (ANRS 1295-CIPRA KH001 CAMELIA trial).

Authors:  Laurence Borand; Yoann Madec; Didier Laureillard; Monidarin Chou; Olivier Marcy; Phearavin Pheng; Narom Prak; Chindamony Kim; Khemarin Kim Lak; Chanroeun Hak; Bunnet Dim; Eric Nerrienet; Arnaud Fontanet; Thim Sok; Anne E Goldfeld; François-Xavier Blanc; Anne-Marie Taburet
Journal:  PLoS One       Date:  2014-03-07       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.